The global Human Rabies Vaccines market is projected to grow from US$ 1098.8 million in 2023 to US$ 1352.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

Human Rabies Vaccines Market

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.

There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.

Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.

Report Includes:

This report presents an overview of global market for Human Rabies Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Human Rabies Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Human Rabies Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Human Rabies Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Human Rabies Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Human Rabies Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Sanofi Pasteur，Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck＆Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd. and Medimmune LLC, etc.

Scope of Human Rabies Vaccines Market Report

Report Metric	Details
Report Name	Human Rabies Vaccines Market
Accounted market size in 2023	US$ 1098.8 million
Forecasted market size in 2029	US$ 1352.3 million
CAGR	3.5
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Vero Cell Rabies Vaccine BHK Chick Embryo Cell Rabies Vaccine Others
Segment by Application	Pre-Exposure Prophylaxis Post-Exposure Prophylaxis
Segment by Region	US & Canada U.S. Canada China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Europe Germany France U.K. Italy Russia Middle East, Africa, Latin America Brazil Mexico Turkey Israel GCC Countries
By Company	Sanofi Pasteur，Inc., Novartis Vaccines and Diagnostics Ltd., Cadila Pharmaceuticals Ltd., GlaxoSmithKline Biologicals, Merck＆Co Inc., Wyeth pharmaceuticals, Berna Biotech Ltd., Medimmune LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Human Rabies Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Human Rabies Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Human Rabies Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Human Rabies Vaccines Market growing?

Ans: The Human Rabies Vaccines Market witnessing a CAGR of 3.5 during the forecast period 2023-2029.

What is the Human Rabies Vaccines Market size in 2029?

Ans: The global Human Rabies Vaccines market is projected to grow from US$ 1098.8 million in 2023 to US$ 1352.3 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period.

What is the Human Rabies Vaccines Market share by region?

Ans: Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

1 Study Coverage

1.1 Human Rabies Vaccines Product Introduction

1.2 Market by Type

1.2.1 Global Human Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Vero Cell Rabies Vaccine

1.2.3 BHK

1.2.4 Chick Embryo Cell Rabies Vaccine

1.2.5 Others

1.3 Market by Application

1.3.1 Global Human Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Pre-Exposure Prophylaxis

1.3.3 Post-Exposure Prophylaxis

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Human Rabies Vaccines Sales Estimates and Forecasts 2018-2029

2.2 Global Human Rabies Vaccines Revenue by Region

2.2.1 Global Human Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Human Rabies Vaccines Revenue by Region (2018-2023)

2.2.3 Global Human Rabies Vaccines Revenue by Region (2024-2029)

2.2.4 Global Human Rabies Vaccines Revenue Market Share by Region (2018-2029)

2.3 Global Human Rabies Vaccines Sales Estimates and Forecasts 2018-2029

2.4 Global Human Rabies Vaccines Sales by Region

2.4.1 Global Human Rabies Vaccines Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Human Rabies Vaccines Sales by Region (2018-2023)

2.4.3 Global Human Rabies Vaccines Sales by Region (2024-2029)

2.4.4 Global Human Rabies Vaccines Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Human Rabies Vaccines Sales by Manufacturers

3.1.1 Global Human Rabies Vaccines Sales by Manufacturers (2018-2023)

3.1.2 Global Human Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Rabies Vaccines in 2022

3.2 Global Human Rabies Vaccines Revenue by Manufacturers

3.2.1 Global Human Rabies Vaccines Revenue by Manufacturers (2018-2023)

3.2.2 Global Human Rabies Vaccines Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Human Rabies Vaccines Revenue in 2022

3.3 Global Key Players of Human Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Human Rabies Vaccines Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Human Rabies Vaccines, Product Offered and Application

3.8 Global Key Manufacturers of Human Rabies Vaccines, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Human Rabies Vaccines Sales by Type

4.1.1 Global Human Rabies Vaccines Historical Sales by Type (2018-2023)

4.1.2 Global Human Rabies Vaccines Forecasted Sales by Type (2024-2029)

4.1.3 Global Human Rabies Vaccines Sales Market Share by Type (2018-2029)

4.2 Global Human Rabies Vaccines Revenue by Type

4.2.1 Global Human Rabies Vaccines Historical Revenue by Type (2018-2023)

4.2.2 Global Human Rabies Vaccines Forecasted Revenue by Type (2024-2029)

4.2.3 Global Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

4.3 Global Human Rabies Vaccines Price by Type

4.3.1 Global Human Rabies Vaccines Price by Type (2018-2023)

4.3.2 Global Human Rabies Vaccines Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Human Rabies Vaccines Sales by Application

5.1.1 Global Human Rabies Vaccines Historical Sales by Application (2018-2023)

5.1.2 Global Human Rabies Vaccines Forecasted Sales by Application (2024-2029)

5.1.3 Global Human Rabies Vaccines Sales Market Share by Application (2018-2029)

5.2 Global Human Rabies Vaccines Revenue by Application

5.2.1 Global Human Rabies Vaccines Historical Revenue by Application (2018-2023)

5.2.2 Global Human Rabies Vaccines Forecasted Revenue by Application (2024-2029)

5.2.3 Global Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

5.3 Global Human Rabies Vaccines Price by Application

5.3.1 Global Human Rabies Vaccines Price by Application (2018-2023)

5.3.2 Global Human Rabies Vaccines Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Human Rabies Vaccines Market Size by Type

6.1.1 US & Canada Human Rabies Vaccines Sales by Type (2018-2029)

6.1.2 US & Canada Human Rabies Vaccines Revenue by Type (2018-2029)

6.2 US & Canada Human Rabies Vaccines Market Size by Application

6.2.1 US & Canada Human Rabies Vaccines Sales by Application (2018-2029)

6.2.2 US & Canada Human Rabies Vaccines Revenue by Application (2018-2029)

6.3 US & Canada Human Rabies Vaccines Market Size by Country

6.3.1 US & Canada Human Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Human Rabies Vaccines Sales by Country (2018-2029)

6.3.3 US & Canada Human Rabies Vaccines Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Human Rabies Vaccines Market Size by Type

7.1.1 Europe Human Rabies Vaccines Sales by Type (2018-2029)

7.1.2 Europe Human Rabies Vaccines Revenue by Type (2018-2029)

7.2 Europe Human Rabies Vaccines Market Size by Application

7.2.1 Europe Human Rabies Vaccines Sales by Application (2018-2029)

7.2.2 Europe Human Rabies Vaccines Revenue by Application (2018-2029)

7.3 Europe Human Rabies Vaccines Market Size by Country

7.3.1 Europe Human Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Human Rabies Vaccines Sales by Country (2018-2029)

7.3.3 Europe Human Rabies Vaccines Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Human Rabies Vaccines Market Size

8.1.1 China Human Rabies Vaccines Sales (2018-2029)

8.1.2 China Human Rabies Vaccines Revenue (2018-2029)

8.2 China Human Rabies Vaccines Market Size by Application

8.2.1 China Human Rabies Vaccines Sales by Application (2018-2029)

8.2.2 China Human Rabies Vaccines Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Human Rabies Vaccines Market Size by Type

9.1.1 Asia Human Rabies Vaccines Sales by Type (2018-2029)

9.1.2 Asia Human Rabies Vaccines Revenue by Type (2018-2029)

9.2 Asia Human Rabies Vaccines Market Size by Application

9.2.1 Asia Human Rabies Vaccines Sales by Application (2018-2029)

9.2.2 Asia Human Rabies Vaccines Revenue by Application (2018-2029)

9.3 Asia Human Rabies Vaccines Sales by Region

9.3.1 Asia Human Rabies Vaccines Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Human Rabies Vaccines Revenue by Region (2018-2029)

9.3.3 Asia Human Rabies Vaccines Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Human Rabies Vaccines Market Size by Type

10.1.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Human Rabies Vaccines Market Size by Application

10.2.1 Middle East, Africa and Latin America Human Rabies Vaccines Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Human Rabies Vaccines Sales by Country

10.3.1 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Human Rabies Vaccines Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Sanofi Pasteur，Inc.

11.1.1 Sanofi Pasteur，Inc. Company Information

11.1.2 Sanofi Pasteur，Inc. Overview

11.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Sanofi Pasteur，Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Sanofi Pasteur，Inc. Recent Developments

11.2 Novartis Vaccines and Diagnostics Ltd.

11.2.1 Novartis Vaccines and Diagnostics Ltd. Company Information

11.2.2 Novartis Vaccines and Diagnostics Ltd. Overview

11.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Novartis Vaccines and Diagnostics Ltd. Recent Developments

11.3 Cadila Pharmaceuticals Ltd.

11.3.1 Cadila Pharmaceuticals Ltd. Company Information

11.3.2 Cadila Pharmaceuticals Ltd. Overview

11.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Cadila Pharmaceuticals Ltd. Recent Developments

11.4 GlaxoSmithKline Biologicals

11.4.1 GlaxoSmithKline Biologicals Company Information

11.4.2 GlaxoSmithKline Biologicals Overview

11.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 GlaxoSmithKline Biologicals Recent Developments

11.5 Merck＆Co Inc.

11.5.1 Merck＆Co Inc. Company Information

11.5.2 Merck＆Co Inc. Overview

11.5.3 Merck＆Co Inc. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Merck＆Co Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Merck＆Co Inc. Recent Developments

11.6 Wyeth pharmaceuticals

11.6.1 Wyeth pharmaceuticals Company Information

11.6.2 Wyeth pharmaceuticals Overview

11.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Wyeth pharmaceuticals Recent Developments

11.7 Berna Biotech Ltd.

11.7.1 Berna Biotech Ltd. Company Information

11.7.2 Berna Biotech Ltd. Overview

11.7.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.7.4 Berna Biotech Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Berna Biotech Ltd. Recent Developments

11.8 Medimmune LLC

11.8.1 Medimmune LLC Company Information

11.8.2 Medimmune LLC Overview

11.8.3 Medimmune LLC Human Rabies Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)

11.8.4 Medimmune LLC Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Medimmune LLC Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Human Rabies Vaccines Industry Chain Analysis

12.2 Human Rabies Vaccines Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Human Rabies Vaccines Production Mode & Process

12.4 Human Rabies Vaccines Sales and Marketing

12.4.1 Human Rabies Vaccines Sales Channels

12.4.2 Human Rabies Vaccines Distributors

12.5 Human Rabies Vaccines Customers

13 Market Dynamics

13.1 Human Rabies Vaccines Industry Trends

13.2 Human Rabies Vaccines Market Drivers

13.3 Human Rabies Vaccines Market Challenges

13.4 Human Rabies Vaccines Market Restraints

14 Key Findings in The Global Human Rabies Vaccines Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur，Inc.

Novartis Vaccines and Diagnostics Ltd.

Cadila Pharmaceuticals Ltd

GlaxoSmithKline Biologicals

Merck& Co. Inc

Wyeth Pharmaceuticals

Berna Biotech Ltd.

MedImmune

List of Tables

Table 1. Global Human Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Vero Cell Rabies Vaccine

Table 3. Major Manufacturers of BHK

Table 4. Major Manufacturers of Chick Embryo Cell Rabies Vaccine

Table 5. Major Manufacturers of Others

Table 6. Global Human Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Human Rabies Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)

Table 9. Global Human Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)

Table 10. Global Human Rabies Vaccines Revenue Market Share by Region (2018-2023)

Table 11. Global Human Rabies Vaccines Revenue Market Share by Region (2024-2029)

Table 12. Global Human Rabies Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 13. Global Human Rabies Vaccines Sales by Region (2018-2023) & (K Units)

Table 14. Global Human Rabies Vaccines Sales by Region (2024-2029) & (K Units)

Table 15. Global Human Rabies Vaccines Sales Market Share by Region (2018-2023)

Table 16. Global Human Rabies Vaccines Sales Market Share by Region (2024-2029)

Table 17. Global Human Rabies Vaccines Sales by Manufacturers (2018-2023) & (K Units)

Table 18. Global Human Rabies Vaccines Sales Share by Manufacturers (2018-2023)

Table 19. Global Human Rabies Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)

Table 20. Global Human Rabies Vaccines Revenue Share by Manufacturers (2018-2023)

Table 21. Global Key Players of Human Rabies Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

Table 22. Human Rabies Vaccines Price by Manufacturers 2018-2023 (USD/Unit)

Table 23. Global Human Rabies Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Human Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccines as of 2022)

Table 25. Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Human Rabies Vaccines, Product Offered and Application

Table 27. Global Key Manufacturers of Human Rabies Vaccines, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 30. Global Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 31. Global Human Rabies Vaccines Sales Share by Type (2018-2023)

Table 32. Global Human Rabies Vaccines Sales Share by Type (2024-2029)

Table 33. Global Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 34. Global Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 35. Global Human Rabies Vaccines Revenue Share by Type (2018-2023)

Table 36. Global Human Rabies Vaccines Revenue Share by Type (2024-2029)

Table 37. Human Rabies Vaccines Price by Type (2018-2023) & (USD/Unit)

Table 38. Global Human Rabies Vaccines Price Forecast by Type (2024-2029) & (USD/Unit)

Table 39. Global Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 40. Global Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 41. Global Human Rabies Vaccines Sales Share by Application (2018-2023)

Table 42. Global Human Rabies Vaccines Sales Share by Application (2024-2029)

Table 43. Global Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 44. Global Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 45. Global Human Rabies Vaccines Revenue Share by Application (2018-2023)

Table 46. Global Human Rabies Vaccines Revenue Share by Application (2024-2029)

Table 47. Human Rabies Vaccines Price by Application (2018-2023) & (USD/Unit)

Table 48. Global Human Rabies Vaccines Price Forecast by Application (2024-2029) & (USD/Unit)

Table 49. US & Canada Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 50. US & Canada Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 51. US & Canada Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 52. US & Canada Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 53. US & Canada Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 54. US & Canada Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 55. US & Canada Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 56. US & Canada Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 57. US & Canada Human Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 58. US & Canada Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)

Table 59. US & Canada Human Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)

Table 60. US & Canada Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)

Table 61. US & Canada Human Rabies Vaccines Sales by Country (2024-2029) & (K Units)

Table 62. Europe Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 63. Europe Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 64. Europe Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 65. Europe Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 66. Europe Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 67. Europe Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 68. Europe Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 69. Europe Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 70. Europe Human Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 71. Europe Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)

Table 72. Europe Human Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)

Table 73. Europe Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)

Table 74. Europe Human Rabies Vaccines Sales by Country (2024-2029) & (K Units)

Table 75. China Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 76. China Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 77. China Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 78. China Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 79. China Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 80. China Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 81. China Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 82. China Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 83. Asia Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 84. Asia Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 85. Asia Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 86. Asia Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 87. Asia Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 88. Asia Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 89. Asia Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 90. Asia Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 91. Asia Human Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 92. Asia Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)

Table 93. Asia Human Rabies Vaccines Revenue by Region (2024-2029) & (US$ Million)

Table 94. Asia Human Rabies Vaccines Sales by Region (2018-2023) & (K Units)

Table 95. Asia Human Rabies Vaccines Sales by Region (2024-2029) & (K Units)

Table 96. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Type (2018-2023) & (K Units)

Table 97. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Type (2024-2029) & (K Units)

Table 98. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2018-2023) & (US$ Million)

Table 99. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Type (2024-2029) & (US$ Million)

Table 100. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Application (2018-2023) & (K Units)

Table 101. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Application (2024-2029) & (K Units)

Table 102. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2018-2023) & (US$ Million)

Table 103. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Application (2024-2029) & (US$ Million)

Table 104. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 105. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)

Table 106. Middle East, Africa and Latin America Human Rabies Vaccines Revenue by Country (2024-2029) & (US$ Million)

Table 107. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)

Table 108. Middle East, Africa and Latin America Human Rabies Vaccines Sales by Country (2024-2029) & (K Units)

Table 109. Sanofi Pasteur，Inc. Company Information

Table 110. Sanofi Pasteur，Inc. Description and Major Businesses

Table 111. Sanofi Pasteur，Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 112. Sanofi Pasteur，Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Sanofi Pasteur，Inc. Recent Developments

Table 114. Novartis Vaccines and Diagnostics Ltd. Company Information

Table 115. Novartis Vaccines and Diagnostics Ltd. Description and Major Businesses

Table 116. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 117. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Novartis Vaccines and Diagnostics Ltd. Recent Developments

Table 119. Cadila Pharmaceuticals Ltd. Company Information

Table 120. Cadila Pharmaceuticals Ltd. Description and Major Businesses

Table 121. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 122. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Cadila Pharmaceuticals Ltd. Recent Developments

Table 124. GlaxoSmithKline Biologicals Company Information

Table 125. GlaxoSmithKline Biologicals Description and Major Businesses

Table 126. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 127. GlaxoSmithKline Biologicals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. GlaxoSmithKline Biologicals Recent Developments

Table 129. Merck＆Co Inc. Company Information

Table 130. Merck＆Co Inc. Description and Major Businesses

Table 131. Merck＆Co Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 132. Merck＆Co Inc. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Merck＆Co Inc. Recent Developments

Table 134. Wyeth pharmaceuticals Company Information

Table 135. Wyeth pharmaceuticals Description and Major Businesses

Table 136. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 137. Wyeth pharmaceuticals Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. Wyeth pharmaceuticals Recent Developments

Table 139. Berna Biotech Ltd. Company Information

Table 140. Berna Biotech Ltd. Description and Major Businesses

Table 141. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 142. Berna Biotech Ltd. Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. Berna Biotech Ltd. Recent Developments

Table 144. Medimmune LLC Company Information

Table 145. Medimmune LLC Description and Major Businesses

Table 146. Medimmune LLC Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

Table 147. Medimmune LLC Human Rabies Vaccines Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Medimmune LLC Recent Developments

Table 149. Key Raw Materials Lists

Table 150. Raw Materials Key Suppliers Lists

Table 151. Human Rabies Vaccines Distributors List

Table 152. Human Rabies Vaccines Customers List

Table 153. Human Rabies Vaccines Market Trends

Table 154. Human Rabies Vaccines Market Drivers

Table 155. Human Rabies Vaccines Market Challenges

Table 156. Human Rabies Vaccines Market Restraints

Table 157. Research Programs/Design for This Report

Table 158. Key Data Information from Secondary Sources

Table 159. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Rabies Vaccines Product Picture

Figure 2. Global Human Rabies Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Human Rabies Vaccines Market Share by Type in 2022 & 2029

Figure 4. Vero Cell Rabies Vaccine Product Picture

Figure 5. BHK Product Picture

Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture

Figure 7. Others Product Picture

Figure 8. Global Human Rabies Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 9. Global Human Rabies Vaccines Market Share by Application in 2022 & 2029

Figure 10. Pre-Exposure Prophylaxis

Figure 11. Post-Exposure Prophylaxis

Figure 12. Human Rabies Vaccines Report Years Considered

Figure 13. Global Human Rabies Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Human Rabies Vaccines Revenue 2018-2029 (US$ Million)

Figure 15. Global Human Rabies Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 16. Global Human Rabies Vaccines Revenue Market Share by Region (2018-2029)

Figure 17. Global Human Rabies Vaccines Sales 2018-2029 ((K Units)

Figure 18. Global Human Rabies Vaccines Sales Market Share by Region (2018-2029)

Figure 19. US & Canada Human Rabies Vaccines Sales YoY (2018-2029) & (K Units)

Figure 20. US & Canada Human Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)

Figure 21. Europe Human Rabies Vaccines Sales YoY (2018-2029) & (K Units)

Figure 22. Europe Human Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)

Figure 23. China Human Rabies Vaccines Sales YoY (2018-2029) & (K Units)

Figure 24. China Human Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)

Figure 25. Asia (excluding China) Human Rabies Vaccines Sales YoY (2018-2029) & (K Units)

Figure 26. Asia (excluding China) Human Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Human Rabies Vaccines Sales YoY (2018-2029) & (K Units)

Figure 28. Middle East, Africa and Latin America Human Rabies Vaccines Revenue YoY (2018-2029) & (US$ Million)

Figure 29. The Human Rabies Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 30. The Top 5 and 10 Largest Manufacturers of Human Rabies Vaccines in the World: Market Share by Human Rabies Vaccines Revenue in 2022

Figure 31. Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 32. Global Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 33. Global Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 34. Global Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 35. Global Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 36. US & Canada Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 37. US & Canada Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 38. US & Canada Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 39. US & Canada Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 40. US & Canada Human Rabies Vaccines Revenue Share by Country (2018-2029)

Figure 41. US & Canada Human Rabies Vaccines Sales Share by Country (2018-2029)

Figure 42. U.S. Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 43. Canada Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 44. Europe Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 45. Europe Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 46. Europe Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 47. Europe Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 48. Europe Human Rabies Vaccines Revenue Share by Country (2018-2029)

Figure 49. Europe Human Rabies Vaccines Sales Share by Country (2018-2029)

Figure 50. Germany Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 51. France Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 52. U.K. Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 53. Italy Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 54. Russia Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 55. China Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 56. China Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 57. China Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 58. China Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 59. Asia Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 60. Asia Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 61. Asia Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 62. Asia Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 63. Asia Human Rabies Vaccines Revenue Share by Region (2018-2029)

Figure 64. Asia Human Rabies Vaccines Sales Share by Region (2018-2029)

Figure 65. Japan Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 66. South Korea Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 67. China Taiwan Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 68. Southeast Asia Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 69. India Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Human Rabies Vaccines Sales Market Share by Type (2018-2029)

Figure 71. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Market Share by Type (2018-2029)

Figure 72. Middle East, Africa and Latin America Human Rabies Vaccines Sales Market Share by Application (2018-2029)

Figure 73. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Market Share by Application (2018-2029)

Figure 74. Middle East, Africa and Latin America Human Rabies Vaccines Revenue Share by Country (2018-2029)

Figure 75. Middle East, Africa and Latin America Human Rabies Vaccines Sales Share by Country (2018-2029)

Figure 76. Brazil Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 77. Mexico Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 78. Turkey Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 79. Israel Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 80. GCC Countries Human Rabies Vaccines Revenue (2018-2029) & (US$ Million)

Figure 81. Human Rabies Vaccines Value Chain

Figure 82. Human Rabies Vaccines Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions